RiverVest Venture Fund III, L.P. 13D and 13G filings for Spruce Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-10 11:05 am Sale | 2025-01-07 | 13D | Spruce Biosciences, Inc. SPRB | RiverVest Venture Fund III, L.P. | 1,759,521 4.200% | -1,767,760 (-50.12%) | Filing |
| 2023-05-30 4:48 pm Purchase | 2023-02-16 | 13D | Spruce Biosciences, Inc. SPRB | RiverVest Venture Fund III, L.P. | 3,527,281 8.600% | 1,379,000 (+64.19%) | Filing |
| 2020-10-23 09:27 am Purchase | 2020-10-14 | 13D | Spruce Biosciences, Inc. SPRB | RiverVest Venture Fund III, L.P. | 2,148,281 9.300% | 2,148,281 (New Position) | Filing |